NIH #5U24CA264029-05
Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing Data
Expiring Soon
- Amount
- $397K
- Period
- 2021-09-20 → 2026-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5U24CA264029-04
Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing Data
Expiring Soon
- Amount
- $378K
- Period
- 2021-09-20 → 2026-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5U24CA264029-03
Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing Data
Expiring Soon
- Amount
- $376K
- Period
- 2021-09-20 → 2026-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5U24CA264029-02
Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing Data
Expiring Soon
- Amount
- $376K
- Period
- 2021-09-20 → 2026-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #1U24CA264029-01
Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing Data
Expiring Soon
- Amount
- $384K
- Period
- 2021-09-20 → 2026-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #1R01CA303137-01A1
Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade glioma
Active
- Amount
- $722K
- Period
- 2026-06-05 → 2031-05-31
- PIs
- 2
- Est. capacity / PI
- ~5 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA262462-05
Synthetic lethalities to cell cycle disruption in glioma
Active
- Amount
- $673K
- Period
- 2022-05-13 → 2027-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA262462-04
Synthetic lethalities to cell cycle disruption in glioma
Active
- Amount
- $673K
- Period
- 2022-05-13 → 2027-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA262462-03
Synthetic lethalities to cell cycle disruption in glioma
Active
- Amount
- $640K
- Period
- 2022-05-13 → 2027-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA262462-02
Synthetic lethalities to cell cycle disruption in glioma
Active
- Amount
- $660K
- Period
- 2022-05-13 → 2027-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #1R01CA262462-01A1
Synthetic lethalities to cell cycle disruption in glioma
Active
- Amount
- $669K
- Period
- 2022-05-13 → 2027-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA188228-10
Evolution of gliomas during treatment and resistance
- Amount
- $698K
- Period
- 2015-04-01 → 2026-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA188228-09
Evolution of gliomas during treatment and resistance
- Amount
- $663K
- Period
- 2015-04-01 → 2026-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA188228-08
Evolution of gliomas during treatment and resistance
- Amount
- $684K
- Period
- 2015-04-01 → 2026-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA188228-07
Evolution of gliomas during treatment and resistance
- Amount
- $684K
- Period
- 2015-04-01 → 2026-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #2R01CA188228-06
Evolution of gliomas during treatment and resistance
- Amount
- $737K
- Period
- 2015-04-01 → 2026-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA219943-05
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
- Amount
- $523K
- Period
- 2017-09-01 → 2023-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5R01CA215489-05
MYB family alterations in pediatric gliomas
- Amount
- $555K
- Period
- 2017-04-01 → 2023-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA219943-04
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
- Amount
- $518K
- Period
- 2017-09-01 → 2022-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5R01CA219943-03
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
- Amount
- $497K
- Period
- 2017-09-01 → 2022-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5R01CA219943-02
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
- Amount
- $508K
- Period
- 2017-09-01 → 2022-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #1R01CA219943-01
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
- Amount
- $503K
- Period
- 2017-09-01 → 2022-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5R01CA215489-04
MYB family alterations in pediatric gliomas
- Amount
- $555K
- Period
- 2017-04-01 → 2022-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA215489-03
MYB family alterations in pediatric gliomas
- Amount
- $538K
- Period
- 2017-04-01 → 2022-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA215489-02
MYB family alterations in pediatric gliomas
- Amount
- $555K
- Period
- 2017-04-01 → 2022-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #1R01CA215489-01
MYB family alterations in pediatric gliomas
- Amount
- $555K
- Period
- 2017-04-01 → 2022-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5U24CA210978-05
Center for the comprehensive analysis of somatic copy-number alterations in cancer
- Amount
- $445K
- Period
- 2016-09-15 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5U24CA210978-04
Center for the comprehensive analysis of somatic copy-number alterations in cancer
- Amount
- $440K
- Period
- 2016-09-15 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5U24CA210978-03
Center for the comprehensive analysis of somatic copy-number alterations in cancer
- Amount
- $462K
- Period
- 2016-09-15 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5U24CA210978-02
Center for the comprehensive analysis of somatic copy-number alterations in cancer
- Amount
- $467K
- Period
- 2016-09-15 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #1U24CA210978-01
Center for the comprehensive analysis of somatic copy-number alterations in cancer
- Amount
- $472K
- Period
- 2016-09-15 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
NIH #5R01CA188228-05
Genetic evolution of glioblastomas during radiation and temozolomide therapy
- Amount
- $657K
- Period
- 2015-04-01 → 2020-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA188228-04
Genetic evolution of glioblastomas during radiation and temozolomide therapy
- Amount
- $683K
- Period
- 2015-04-01 → 2020-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA188228-03
Genetic evolution of glioblastomas during radiation and temozolomide therapy
- Amount
- $689K
- Period
- 2015-04-01 → 2020-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA188228-02
Genetic evolution of glioblastomas during radiation and temozolomide therapy
- Amount
- $697K
- Period
- 2015-04-01 → 2020-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #1R01CA188228-01A1
Genetic evolution of glioblastomas during radiation and temozolomide therapy
- Amount
- $704K
- Period
- 2015-04-01 → 2020-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5K08CA122833-05
High-resolution genome-wide mapping of structural mutations in prostate cancer
- Amount
- $139K
- Period
- 2007-06-12 → 2012-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5K08CA122833-04
High-resolution genome-wide mapping of structural mutations in prostate cancer
- Amount
- $139K
- Period
- 2007-06-12 → 2012-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5K08CA122833-03
High-resolution genome-wide mapping of structural mutations in prostate cancer
- Amount
- $139K
- Period
- 2007-06-12 → 2012-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5K08CA122833-02
High-resolution genome-wide mapping of structural mutations in prostate cancer
- Amount
- $139K
- Period
- 2007-06-12 → 2012-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #1K08CA122833-01A1
High-resolution genome-wide mapping of structural mutations in prostate cancer
- Amount
- $139K
- Period
- 2007-06-12 → 2012-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST